Youn Jennifer, Hsia Katie, Khadilkar Surya, Zeina Tanya, Rai Puja, Rastogi Akash, Hussani Sureya, Spence Samara, Adavelly Pranay, Yanes Jason, Kotlier Jacob, Sweigart Benjamin, Levy Alexander N, Friedman Sonia
Department of Medicine, Tufts Medical Center, 800 Washington St, Boston, MA, 02111, USA.
Division of Gastroenterology, Tufts University School of Medicine, Boston, USA.
Dig Dis Sci. 2025 Jan;70(1):323-332. doi: 10.1007/s10620-024-08729-7. Epub 2024 Nov 16.
The incidence of obesity in patients with inflammatory bowel disease (IBD) is increasing and there are limited data on the impact of obesity on perianal fistulas in Crohn's disease (CD).
We aim to examine the relationship between obesity and the prevalence and complications of Crohn's perianal fistulas.
We conducted a cross-sectional study of CD patients treated at a tertiary care center from 2012 to 2022. Obesity was defined as maximum BMI > 30 kg/m and further subdivided into 5 BMI categories. The prevalence of perianal fistulas was defined by any history of perianal fistula. The complications of perianal fistulas were measured by five variables including complex fistulas, history of perianal fistula surgery, number of perianal surgeries, history of fecal diversion, and median time to first anal surgery.
In all, 704 patients with CD were included; 31.1% were obese. There was no significant association between obesity and prevalence of perianal fistulas (p = 0.719), complex fistulas (p = 0.144), history of perianal surgery (p = 0.146), ≥ 1 perianal surgeries (p = 0.220), fecal diversion (p = 0.705), or median time to first perianal surgery (p = 0.192). Increasing BMI category was not associated with the prevalence of perianal fistulas (p = 0.944), complex fistulas (p = 0.089), perianal surgery (p = 0.583), ≥ 1 perianal surgeries (p = 0.114), fecal diversion (p = 0.542), or median time to first perianal surgery (p = 0.486). When comparing those with perianal fistulas to those without, there was no significant difference in rates of obesity (p = 0.876).
There was no association between obesity and the prevalence and complications of Crohn's perianal fistulas.
炎症性肠病(IBD)患者的肥胖发生率正在上升,而关于肥胖对克罗恩病(CD)肛周瘘管影响的数据有限。
我们旨在研究肥胖与克罗恩病肛周瘘管的患病率及并发症之间的关系。
我们对2012年至2022年在一家三级医疗中心接受治疗的CD患者进行了一项横断面研究。肥胖定义为最大体重指数(BMI)>30kg/m²,并进一步细分为5个BMI类别。肛周瘘管的患病率由任何肛周瘘管病史确定。肛周瘘管的并发症通过五个变量来衡量,包括复杂性瘘管、肛周瘘管手术史、肛周手术次数、粪便转流病史以及首次肛门手术的中位时间。
总共纳入了704例CD患者;31.1%为肥胖患者。肥胖与肛周瘘管的患病率(p = 0.719)、复杂性瘘管(p = 0.144)、肛周手术史(p = 0.146)、≥1次肛周手术(p = 0.220)、粪便转流(p = 0.705)或首次肛周手术的中位时间(p = 0.192)之间均无显著关联。BMI类别增加与肛周瘘管的患病率(p = 0.944)、复杂性瘘管(p = 0.089)、肛周手术(p = 0.583)、≥1次肛周手术(p = 0.114)、粪便转流(p = 0.542)或首次肛周手术的中位时间(p = 0.486)均无关联。将有肛周瘘管的患者与无肛周瘘管的患者进行比较时,肥胖率无显著差异(p = 0.876)。
肥胖与克罗恩病肛周瘘管的患病率及并发症之间无关联。